Put companies on watchlist
Cenit AG
ISIN: DE0005407100
WKN: 540710
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Cenit AG · ISIN: DE0005407100 · EQS - Analysts (69 News)
Country: Germany · Primary market: Germany · EQS NID: 21203
07 November 2024 10:02AM

Buy


Original-Research: Cenit AG - from GBC AG

07.11.2024 / 10:01 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of GBC AG to Cenit AG

Company Name: Cenit AG
ISIN: DE0005407100
 
Reason for the research: Research Comment
Recommendation: Buy
Target price: EUR 22.00
Target price on sight of: 31.12.2025
Last rating change:
Analyst: Cosmin Filker, Marcel Goldmann

9M 2024: Sales benefit from inorganic growth, earnings weighed down by one-off effects, guidance and our forecasts reduced, price target lowered to €22.00, Rating: BUY

Both organic and inorganic effects contributed to the 13.6 % increase in CENIT AG's revenue to €151.43 million (previous year: €133.31 million) in the first nine months of 2024. The companies CCE GmbH (acquired on 3 January 2024) and Analysis Prime LLC (acquired on 17 July 2024), which were acquired in the current financial year 2024 alone, have contributed revenue of €7.52 million since joining the group. Adjusted for the contributions of the two companies and for the base effect of the companies acquired in the previous year, which are now included for the full reporting period, organic growth was 4.3 %, close to the company's target of 5.0 %. 

The increase in sales revenue was offset by a decline in EBIT to €3.97 million (previous year: €4.60 million) and thus in the EBIT margin to 2.6% (previous year: 3.5%). This is mainly due to the acquisition-related expenses and the associated sharp increase in depreciation on acquired assets. While depreciation increased by €1.36 million, the acquisition costs amounted to €0.82 million. In addition, there was a negative one-off effect (€0.87 million) from the deconsolidation of the Japanese subsidiary. Adjusted for the special effects, CENIT AG would have achieved an increase in EBIT to €4.67 million (previous year: €3.95 million).

Despite the significant decline in EBIT, CENIT AG again generated a high cash flow from operating activities of €9.91 million (previous year: €8.50 million). This covered a significant portion of the purchase price for the two corporate acquisitions (€13.96 million). Together with the repayment of bank liabilities, the company continues to have sufficient cash and cash equivalents of €12.18 million.

In the run-up to the publication of the nine-month report, CENIT's management adjusted its forecast. On the sales side, the contribution of the acquired Analysis Prime was included in the guidance for the first time, with the company expecting sales of € 205 - 210 million (previously: € 197 - 202 million). However, adjusted for the inorganic effect, this corresponds to a slight reduction in the guidance, as the originally expected revenue contribution of Analysis Prime of USD 11.5 million (€10.6 million) would have led to a new guidance of €207.6 - 212.6 million. According to the company, this is due to the current weak demand from the automotive and aerospace industries, which is likely to lead to lower demand for single licences in the fourth quarter of 2024. However, delays in the start of the Analysis Prime order have also led to a reduction in revenue expectations at this company. The expected gross profit loss of around €7m coincides with extraordinary expenses that have already been incurred and higher depreciation (PPA depreciation), meaning that the company expects EBIT to fall to between €8.0m and €8.5m.

We are adjusting our forecasts to the new guidance and, on this basis, are reducing our forecasts for the coming financial years. The full-year inclusion of Analysis Prime, the cost-cutting measures introduced and the absence of one-off effects should lead to a revenue increase and a significant improvement in the EBIT margin in the coming financial year 2025. This trend should continue into 2026. On the basis of the adjusted forecasts, we have set a new price target of €22.00 (previously: €24.15). We continue to issue a BUY rating.



You can download the research here: http://www.more-ir.de/d/31203.pdf

Contact for questions:
++++++++++++++++
Disclosure of potential conflicts of interest pursuant to Section 85 WpHG and Art. 20 MAR The company analysed above has the following potential conflict of interest: (5a,6a,7,11); A catalogue of potential conflicts of interest can be found at:

https://www.gbc-ag.de/de/Offenlegung.htm
+++++++++++++++
Date and time of completion of the study: 07/11/24 (08:21 am)
Date and time of the first dissemination of the study: 07/11/24 (10:00 am)


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


2024405  07.11.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2024405&application_name=news&site_id=boersengefluester_html
Visual performance / price development - Cenit AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.